...
首页> 外文期刊>Journal of medical screening >Heterozygosity for Tay-Sachs and Sandhoff Diseases among Massachusetts Residents with French Canadian Background
【24h】

Heterozygosity for Tay-Sachs and Sandhoff Diseases among Massachusetts Residents with French Canadian Background

机译:法属加拿大背景的马萨诸塞州居民的泰式-萨克斯氏和桑德霍夫氏病杂合性

获取原文

摘要

Objectives—The frequency of Tay-Sachs disease (TSD) heterozygosity is increased among French Canadians in eastern Quebec. A large proportion of the New England population has French Canadian heritage; thus, it is important to determine if they too are at increased risk for TSD heterozygosity. This prospective study was designed to assess the TSD heterozygote frequency among people with French Canadian background living in Massachusetts. A simultaneous screen for heterozygosity for Sandhoff disease, a related genetic disorder, was also undertaken. Methods—1260 non-pregnant subjects of French Canadian background were included in the study, β hexosaminidase activity was measured in blood samples, and results were evaluated for TSD and Sandhoff disease heterozygosity. Samples from the TSD heterozygotes were also subjected to mutation analysis. Results—Of the 1260 samples studied, 22 (1 in 57; CI 1 in 41, 1 in 98) were identified as TSD heterozygotes by enzymatic analyses and 11 subjects (1 in 114; CI 1 in 72,1 in 280) were identified as Sandhoff disease heterozygotes. Three of the 22 TSD heterozygotes were found to have benign pseudodeficiency mutations, resulting in a maximum TSD heterozygote frequency of 19 in 1260 (1 in 66; CI 1 in 46, 1 in 120). Together, these data provide a maximum frequency of heterozygosity for TSD or Sandhoff disease of 30 in 1260 (1 in 42; CI 1 in 31, 1 in 64) in this population. Conclusions—Simultaneous screening for TSD and Sandhoff disease heterozygosity by assay of β hexosaminidases A and B activities provides a possible method for use with subjects of French Canadian background. The relevance of some of the novel mutations identified in this group needs further study. However, the comparatively high combined frequency of TSD and Sandhoff disease heterozygosity indicates a need for discussion regarding the appropriateness of carrier testing for these disorders for persons of French Canadian background in Massachusetts.
机译:目标-在魁北克东部的法裔加拿大人中,泰-萨克斯病(TSD)杂合的发生率增加。新英格兰人口中有很大一部分是加拿大法裔;因此,重要的是确定它们是否也有增加TSD杂合性的风险。这项前瞻性研究旨在评估居住在马萨诸塞州的加拿大裔法国人中TSD杂合子的频率。同时进行了桑德霍夫病(一种相关的遗传疾病)的杂合性筛查。方法:将1260名法国加拿大背景的未怀孕受试者纳入研究,测量血样中的β己糖胺酶活性,并评估TSD和Sandhoff病杂合性的结果。来自TSD杂合子的样品也进行了突变分析。结果-在1260个样本中,有22个样本(57个样本中的1个; 41个样本中的CI的1个,98个样本中的1个)被酶学分析鉴定为TSD杂合子,11个受试者(114个样本中的1个; 280,72个样本中的CI 1的)如桑霍夫病杂合子。发现22个TSD杂合子中的3个具有良性假缺陷突变,导致最大TSD杂合子频率为1260中的19(66中为1; CI为46中为1,120中为1)。这些数据加在一起提供了该人群中TSD或Sandhoff病杂合性的最高频率,为1260分之30(42分之1; CI的31分之1,64分之1)。结论—通过检测β己糖胺酶A和B活性同时筛查TSD和Sandhoff病杂合性,为法国加拿大背景的受试者提供了一种可能的方法。在该组中鉴定出的某些新型突变的相关性需要进一步研究。然而,TSD和Sandhoff病杂合性的较高合并频率表明,有必要对马萨诸塞州加拿大裔法国人针对这些疾病的携带者检测的适宜性进行讨论。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号